Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • prs321
    Member
    • Jun 2013
    • 96

    #1

    Difference between assembly, gene annotation, and reference genome?

    What are the differences? Why make an assembly when you can just map reads to the reference genome and look for mutations that way?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    That is only possible when a "reference" genome is available. Many do not work with model/well-annotated genomes/organisms.

    If one generates a "great" assembly then it can eventually lead to a "reference genome" which can ultimately be "annotated".

    At that point someone else can come along and do what you proposed above (i.e. map and look for mutations that can be functionally mapped).
    Last edited by GenoMax; 08-29-2013, 09:58 AM.

    Comment

    • prs321
      Member
      • Jun 2013
      • 96

      #3
      So what is considered a "great" assembly?

      Is an assembly constructed by mapping a sample over an available reference and then assembling the sequences into a "better" reference genome? Thus ending up with a better reference genome aka the assembly?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Originally posted by prs321 View Post
        So what is considered a "great" assembly?
        There are bound to be differences of opinion about the definition but something that reasonably accounts for/characterizes a "genome" can be considered one.

        Originally posted by prs321 View Post
        Is an assembly constructed by mapping a sample over an available reference and then assembling the sequences into a "better" reference genome? Thus ending up with a better reference genome aka the assembly?
        Here is a quote from the GRC's main web page that addresses this question.

        The original model for representing the genome assemblies was to use a single, preferred tiling path to produce a single consensus representation of the genome. Subsequent analysis has shown that for most mammalian genomes a single tiling path is insufficient to represent a genome in regions with complex allelic diversity. The GRC is now working to create assemblies that better represent this diversity and provide more robust substrates for genome analysis.

        Comment

        • Wallysb01
          Senior Member
          • Feb 2011
          • 286

          #5
          Originally posted by prs321 View Post
          So what is considered a "great" assembly?
          As Genomax said, there will be a variety of definition of "great", but I think you can break down useful genome assemblies into about 3 catagories of increasing "greatness":

          1) scaffold N50 roughly equals the genome size of a single gene for that organism (for vertebrates this would be roughly 50kbp. Due to the fragmented nature of the genome, hopefully you have a very low percent of Ns in there as well. This would be the kind of genome created from high coverage illumina data or low coverage sanger, but without long scaffolding libraries or physical mapping of contigs/scaffolds to chromosomes.

          For this kind of genome, you could at least find many mostly whole genes to some preliminary work, but it will be difficult to do many of the genomic studies possible in mice/human. Here the sheer number of scaffolds/contigs in your assembly will prove challanging to analyze, as this number can be in the hundreds of thousands.

          2) scaffold N50 increases to include many genes. This would be in the >1Mbp or greater range for vertebrates. For this type of genome, you probably have a lot of gaps, but hopefully your contig N50 is >10Kbp. Now, you'll have synteny blocks. You can start doing more advanced forms of genomic analysis due to the fewer number of contigs/scaffolds (maybe in the low thousands for vertebrates).

          3) scaffolds are now physically mapped to chromosomes, allowing for scaffold N50 to approach the size of small chromosomes (say 50Mbps) and total number of scaffolds approaches the haploid chromosome count for the species. Also, gaps in the genome are systamtically filled in so N% is approaching zero. This has really only been mostly completed, or even attempted, for a handful of genomes to date.

          Is an assembly constructed by mapping a sample over an available reference and then assembling the sequences into a "better" reference genome? Thus ending up with a better reference genome aka the assembly?
          Most genomes are completely de novo, which allows for not biasing your genome towards what ever structure is in the nearest reference genome. But if you're working on a very closely related species with a reference, or maybe a bunch of them, and you don't care about getting the genomes of most them all that correct, this can be a cost effective way to make a genome. Particularly, if you're interested in just presence/absence of SNPs or small indels. But those kinds of genomes come with a lot of caviates, since without a de novo genome assembly its pretty difficult to know just how wrong your reference guided genome assembly might be.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...